| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIO-TECHNE Corp | Director | Common Stock | 15,411 | $857,313 | $55.63 | 30 Oct 2025 | Direct |
| BIO-TECHNE Corp | Director | Stock Options (Right to Buy) | 3,777 | $210,114 | $55.63 | 30 Oct 2025 | Direct |
| Keros Therapeutics, Inc. | Director | Common Stock | 5,250 | $75,810 | $14.44 | 04 Jun 2025 | Direct |
| Keros Therapeutics, Inc. | Director | Stock Option (right to buy) | 10,500 | 04 Jun 2025 | Direct | ||
| Seagen Inc. | Director | Common Stock | 0 | $229.00 | 14 Dec 2023 | Direct | |
| Seagen Inc. | Director | Restricted Stock Units | 0 | $229.00 | 14 Dec 2023 | Direct | |
| Seagen Inc. | Director | Stock Options (Right to Buy) | 0 | 14 Dec 2023 | Direct |